HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sergio Pecorelli Selected Research

hI-con1

10/2011Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
6/2011Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sergio Pecorelli Research Topics

Disease

63Neoplasms (Cancer)
11/2019 - 05/2002
33Carcinoma (Carcinomatosis)
11/2019 - 01/2003
27Ovarian Neoplasms (Ovarian Cancer)
12/2015 - 05/2002
22Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2019 - 06/2002
14Endometrial Neoplasms (Endometrial Cancer)
01/2014 - 08/2004
12Papillary Carcinoma
07/2013 - 10/2004
11Ovarian Epithelial Carcinoma
01/2017 - 08/2002
5Ovarian Diseases (Ovarian Disease)
12/2015 - 07/2009
5Endometrioid Carcinoma
12/2011 - 05/2005
5Neoplasm Metastasis (Metastasis)
06/2007 - 11/2003
4Carcinosarcoma
10/2016 - 06/2007
3Adenocarcinoma
11/2019 - 06/2011
3Anemia
12/2015 - 06/2002
3Ascites
07/2010 - 06/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 06/2011
2Chronic Disease (Chronic Diseases)
02/2016 - 04/2014
2Dementia (Dementias)
01/2016 - 12/2014
1COVID-19
12/2023
1Chronic Obstructive Pulmonary Disease (COPD)
12/2016
1Myocardial Infarction
08/2016

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
09/2013 - 01/2005
13Biomarkers (Surrogate Marker)IBA
01/2017 - 05/2005
10ParaffinIBA
07/2013 - 11/2003
9Messenger RNA (mRNA)IBA
07/2013 - 06/2007
8Claudin-3IBA
12/2015 - 10/2004
8AntigensIBA
10/2015 - 01/2005
7PlatinumIBA
01/2017 - 01/2003
7Peptides (Polypeptides)IBA
12/2015 - 01/2009
7Monoclonal AntibodiesIBA
05/2012 - 07/2009
6Clostridium enterotoxinIBA
12/2015 - 05/2005
6Kallikreins (Kallikrein)IBA
09/2013 - 08/2004
6Paclitaxel (Taxol)FDA LinkGeneric
07/2013 - 08/2004
6Claudin-4IBA
12/2011 - 10/2004
6Serine Proteases (Serine Protease)IBA
08/2009 - 11/2003
6EnzymesIBA
08/2009 - 01/2004
5VaccinesIBA
12/2023 - 01/2005
5Interleukin-2 (IL2)IBA
12/2011 - 03/2006
5Epithelial Cell Adhesion MoleculeIBA
12/2010 - 10/2004
5Peptide Hydrolases (Proteases)FDA Link
08/2009 - 11/2003
5Oncogene Proteins (Oncogene Protein)IBA
07/2009 - 05/2003
4EpitopesIBA
10/2015 - 01/2009
4Formaldehyde (Formol)FDA Link
07/2013 - 10/2004
4Trastuzumab (Herceptin)FDA Link
05/2012 - 05/2002
4ImmunosorbentsIBA
08/2009 - 07/2005
4Epidermal Growth Factor (EGF)IBA
09/2007 - 08/2004
4OligonucleotidesIBA
03/2007 - 10/2004
3DNA (Deoxyribonucleic Acid)IBA
11/2019 - 02/2013
3Mammaglobin BIBA
07/2013 - 06/2007
3Complement System Proteins (Complement)IBA
05/2012 - 09/2007
3adecatumumabIBA
12/2010 - 01/2010
3RNA (Ribonucleic Acid)IBA
07/2009 - 11/2006
31-oleoyl-2-stearoylphosphatidylcholineIBA
03/2007 - 10/2004
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2016 - 08/2016
2Antihypertensive Agents (Antihypertensives)IBA
12/2016 - 02/2016
2Fluorescein-5-isothiocyanate (FITC)IBA
12/2015 - 07/2010
2ErythropoietinFDA Link
12/2015 - 06/2002
2Immunoglobulin G (IgG)IBA
10/2015 - 08/2009
2OsteopontinIBA
09/2013 - 10/2004
2Immunoglobulin M (IgM)IBA
09/2013 - 08/2009
2Papillomavirus Vaccines (HPV Vaccines)IBA
07/2013 - 01/2005
2UteroglobinIBA
07/2013 - 06/2007
2TubulinIBA
07/2013 - 04/2012
2epothilone B (EPO906)IBA
07/2013 - 04/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 03/2007
2Small Interfering RNA (siRNA)IBA
12/2011 - 10/2011
2Tight Junction ProteinsIBA
12/2011 - 05/2005
2Thromboplastin (Tissue Factor)IBA
10/2011 - 06/2011
2hI-con1IBA
10/2011 - 06/2011
2A-factor (Streptomyces)IBA
10/2011 - 06/2011
2IntegrinsIBA
08/2011 - 03/2007
2Rituximab (Mabthera)FDA Link
07/2011 - 06/2011
2Antineoplastic Agents (Antineoplastics)IBA
07/2010 - 07/2009
2Interferon-gamma (Interferon, gamma)IBA
02/2009 - 01/2009
2ErbB-2 ReceptorIBA
08/2008 - 05/2002
2Carboplatin (JM8)FDA LinkGeneric
04/2006 - 08/2004
2Indicators and Reagents (Reagents)IBA
10/2005 - 03/2005
2CytokinesIBA
07/2005 - 01/2005
2Hemoglobins (Hemoglobin)IBA
01/2005 - 06/2002
2matriptaseIBA
10/2004 - 11/2003
2Protein Sorting Signals (Signal Peptide)IBA
08/2004 - 01/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2004 - 11/2003
1AfatinibIBA
11/2019
1copanlisibIBA
11/2019
1neratinibIBA
11/2019
1Cytidine DeaminaseIBA
11/2019
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2016
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2016
1AnticoagulantsIBA
12/2016
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
12/2016
1Histones (Histone)IBA
10/2016
1Nucleosomes (Nucleosome)IBA
10/2016
1HIV Protease InhibitorsIBA
10/2016
1Saquinavir (Invirase)FDA Link
10/2016

Therapy/Procedure

30Drug Therapy (Chemotherapy)
01/2019 - 05/2002
29Therapeutics
11/2019 - 05/2002
17Immunotherapy
05/2012 - 05/2003
7Radiotherapy
08/2008 - 12/2002
3Neoadjuvant Therapy
12/2015 - 08/2002
3Adjuvant Chemotherapy
07/2010 - 01/2003
1Investigational Therapies (Experimental Therapy)
10/2016